AERI Aerie Pharmaceuticals Stock Forecast Outlook:Negative Period (n+30) 19 Feb 2021


Stock Forecast


As of Fri Feb 19 2021 00:00:03 GMT+0000 (Coordinated Universal Time) shares of AERI Aerie Pharmaceuticals -2.16 percentage change in price since the previous day's close. Around 399771 of 46815000 changed hand on the market. The Stock opened at 16.57 with high and low of 16.11 and 16.95 respectively. The price/earnings ratio is: - and earning per share is -4.19. The stock quoted a 52 week high and low of 9.01 and 22.75 respectively.

BOSTON (AI Forecast Terminal) Fri, Feb 19, '21 AI Forecast today took the forecast actions: In the context of stock price realization of AERI Aerie Pharmaceuticals is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+30) for AERI Aerie Pharmaceuticals as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of AERI Aerie Pharmaceuticals as below:

AERI Aerie Pharmaceuticals Credit Rating Overview


We rerate AERI Aerie Pharmaceuticals because Incremental risk charge, comprehensive risk measure. We use econometric methods for period (n+30) simulate with Voltage Controlled Oscillator Logistic Regression. Reference code is: 2265. Beta DRL value REG 38 Rational Demand Factor LD 6224.567999999999. The various qualitative factors in the criteria help to identify strengths and weaknesses within a company's future liquidity position that numerical ratios might not fully capture. While there is no size bias in our liquidity assessment, generally, lower-rated entities might meet the quantitative requirements for strong or exceptional liquidity but fail to meet corresponding qualitative factors. Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for AERI Aerie Pharmaceuticals as below:
Frequently Asked QuestionsQ: What is AERI Aerie Pharmaceuticals stock symbol?
A: AERI Aerie Pharmaceuticals stock referred as NASDAQ:AERI
Q: What is AERI Aerie Pharmaceuticals stock price?
A: On share of AERI Aerie Pharmaceuticals stock can currently be purchased for approximately 16.32
Q: Do analysts recommend investors buy shares of AERI Aerie Pharmaceuticals ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for AERI Aerie Pharmaceuticals at daily forecast section
Q: What is the earning per share of AERI Aerie Pharmaceuticals ?
A: The earning per share of AERI Aerie Pharmaceuticals is -4.19
Q: What is the market capitalization of AERI Aerie Pharmaceuticals ?
A: The market capitalization of AERI Aerie Pharmaceuticals is 764020785
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker, credit rating agency or route orders containing equities securities. In our Machine Learning experiment, we focus on an approach known as Decision making using game theory. We apply principles from game theory to model the relationships between rating actions, news, market signals and decision making.The rating information provided is for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. Usage as a credit rating or as a benchmark is not permitted.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com